Skip to Content

Distillate US Fdmtl Stblty & Val ETF DSTL

Medalist Rating as of | See Distillate Capital Investment Hub

Morningstar’s Analysis DSTL

Will DSTL outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Distillate US Fdmtl Stblty& Val ETF earns a Morningstar Medalist Rating of Neutral with strength in areas such as Process offset by weaker spots such as People.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DSTL

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 19.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Broadcom Inc

2.30 49.5 Mil
Technology

UnitedHealth Group Inc

2.29 49.4 Mil
Healthcare

AbbVie Inc

2.12 45.7 Mil
Healthcare

Alphabet Inc Class A

2.01 43.3 Mil
Communication Services

Visa Inc Class A

2.00 43.2 Mil
Financial Services

The Home Depot Inc

1.89 40.7 Mil
Consumer Cyclical

Johnson & Johnson

1.88 40.5 Mil
Healthcare

Procter & Gamble Co

1.73 37.3 Mil
Consumer Defensive

Bristol-Myers Squibb Co

1.59 34.3 Mil
Healthcare

T-Mobile US Inc

1.56 33.6 Mil
Communication Services